By Danielle Regeneron Pharmaceuticals said on Monday it would buy 23andMe out of bankruptcy for $256 million. The acquisition gives Regeneron the company’s genetic samples…
By Danielle Regeneron Pharmaceuticals said on Monday it would buy 23andMe out of bankruptcy for $256 million. The acquisition gives Regeneron the company’s genetic samples…